Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · cited 1×
“Formation of a cytochrome c/Apaf-1/caspase-9 containing apoptosome complex leads to activation of e ector molecules such as caspase-3 (Li et al., 1997).”
BackgroundInduction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060 · cited 2×
“Mitochondria, cytosolic or nuclear extracts were prepared and analysed as previously described (Susin et al., 1999a; Sca di et al., 1998).”
BackgroundMethodSelf-citationLuo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626 · cited 4×
“In addition, activation of the receptor and the mitochondrial pathway may be interconnected through molecules such as Bid (Li et al., 1998; Luo et al., 1998).”
BackgroundInfluentialMuzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046 · cited 1×
“…such as CD95, the adaptor molecule Fasassociated death domain (FADD) and the receptorproximal caspase-8 are recruited to form a deathinducing signaling complex (DISC) (Trauth et al., 1989; Oehm et al., 1992; Kischkel et al., 1995; Medema et al., 1997; Muzio et al., 1996; Chinnaiyan et al., 1996).”
BackgroundTwo CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Self-citationChinnaiyan, A. M., O'Rourke, K., Tewari, M., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90071-3 · Cited by 2,431
The proto-oncogene Bcl-2 and its role in regulating apoptosis
Kroemer, G. (1997) · Nature Medicine · doi:10.1038/nm0697-614 · Cited by 1,739 · cited 7×
“…is inhibited by anti-apoptotic members of the Bcl-2 family which interfere with the relocalization of cytochrome c or AIF from mitochondria into the cytosol or with the binding of cytochrome c to Apaf-1 (Kroemer, 1997; Marzo et al., 1998a,b; Kluck et al., 1997; Yang et al., 1997; Hu et al., 1998).”
BackgroundSelf-citationReduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9
Kuida, K., Haydar, T. F., Kuan, C.-Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S.-S., Rakic, P., & Flavell, R. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81476-2 · Cited by 1,643
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266 · cited 3×
“…by cytotoxic drugs used as anticancer agents has been reported to involve activation of death receptor/ligand systems such as the CD95 system Oncogene (Debatin, 1997; Kaufmann and Earnshaw, 2000; Fulda et al., 1997, 1998a,b,c,d, 2000; Friesen et al., 1996, 1997, 1999; Houghton et al., 1997).”
Background
Cited by
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
“Also, increased recruitment of FADD and procaspase-8 to the CD95 receptor to form the CD95 DISC was observed in certain tumor cells upon drug treatment in a CD95L-dependent or CD95L-independent manner (Fulda et al., 2001).”
BackgroundSelf-citationJohnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
Doxorubicin-Induced Cardiomyopathy
Takemura, G., & Fujiwara, H. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.002 · Cited by 827
Apoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 826
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K.-M. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 800
Self-citationFulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
Self-citationDeath receptors in chemotherapy and cancer
Debatin, K.-M., & Krammer, P. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207558 · Cited by 505
Self-citationApoptosis pathways in cancer and cancer therapy
Debatin, K.-M. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0474-8 · Cited by 476
Self-citationHypericin in cancer treatment: more light on the way
Agostinis, P., Vantieghem, A., Merlevede, W., & de Witte, P. A. M. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00126-1 · Cited by 469
Mahrus, S., Trinidad, J. C., Barkan, D. T., Sali, A., Burlingame, A. L., & Wells, J. A. (2008) · Cell · doi:10.1016/j.cell.2008.08.012 · Cited by 459
Chemotherapy: targeting the mitochondrial cell death pathway
Debatin, K.-M., Poncet, D., & Kroemer, G. (2002) · Oncogene · doi:10.1038/sj.onc.1206039 · Cited by 396
Self-citationFisher, P. W., Salloum, F., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 355
Kaina, B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00510-0 · Cited by 326
Cisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells
Lacour, S., Hammann, A., Grazide, S., Lagadic-Gossmann, D., Athias, A., Sergent, O., Laurent, G., Gambert, P., Solary, E., & Dimanche-Boitrel, M.-T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2787 · Cited by 306
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Oxygen/Nitrogen Radicals: Cell Injury and Disease · doi:10.1007/978-1-4615-1087-1_13 · Cited by 296
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015976430790 · Cited by 293
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Plati, J., Bucur, O., & Khosravi‐Far, R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21707 · Cited by 293
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., & Toge, T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0522-7 · Cited by 253
El Fajoui, Z., Toscano, F., Jacquemin, G., Abello, J., Scoazec, J., Micheau, O., & Saurin, J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.055 · Cited by 37
Metadata
- Authors
- Fulda, S., Meyer, E., Friesen, C., Susin, S. A., Kroemer, G., & Debatin, K.-M.
- Venue
- Oncogene
- Published
- 2001-03-01
- Volume
- 20
- Issue
- 9
- Pages
- 1063-1075
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2160224004
- Cited by
- 223
- References
- 13
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.